Marshall & Sterling Wealth Advisors Inc. Astrazeneca PLC Transaction History
Marshall & Sterling Wealth Advisors Inc.
- $147 Billion
- Q1 2025
A detailed history of Marshall & Sterling Wealth Advisors Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Marshall & Sterling Wealth Advisors Inc. holds 76 shares of AZN stock, worth $5,393. This represents 0.0% of its overall portfolio holdings.
Number of Shares
76Holding current value
$5,393% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.05 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.89 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.53 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.26 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.22 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $220B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...